Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol SR vs IR in Essential Hypertension
NCT01756430Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Dec 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in essential hypertension, sponsored by Chong Kun Dang Holdings. Started Dec 2012; status: completed.
02
Drugs
carvedilol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01756430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756430.